Morphic Medical

GI Dynamics is Now Morphic Medical. Learn More.

Six Month Results of a Multi-Center, Prospective, Randomized Trial of the Endoscopic Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes in Obese Subjects

This is an interim report of an ongoing one year study. In a prospective, randomized, diet controlled, multicentre study, 77 subjects were included, 38 device and 39 diet controls, treatment 6 months with 6 month follow-up.


How RESET Works

Maintenance of Efficacy After RESET

BBC News Item

DJBL for the Treatment of Type 2 Diabetes and Obesity: EASD 2022